布魯林克斯 BXC 深 滬
等待開盤 06-25 09:30:00 美东时间
60.70
+5.950
+10.87%
華盛通- 最 高60.84
- 今 開55.04
- 成交量 24.46万股
- 最 低 55.00
- 昨 收 54.75
- 總市值 4.72亿
- 52周最高 88.30
- 市盈率 靜 2231.62
- 換手率 3.14%
- 52周最低 44.78
- 委 比 0.00%
- 總股本 778.24万
- 歷史最高 134.792
- 量 比 1.71
- 振 幅 10.67%
- 歷史最低 3.00
- 每 手 1
- 風險率 10.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多These small-cap industrials stocks combine growth and A-rated valuations
Industrials stocks are navigating a challenging environment marked by uneven economic growth, shifting trade dynamics, and ongoing uncertainty around business spending. Despite those headwinds, some s...
06-16 22:52
美股牛股 | 伟创力绩后暴涨近40%！NNE大涨27%，与超微电脑联手探索核能AI数据中心
伟创力绩后暴涨近40%！宣布分拆云计算部门独立上市；NNE大涨27%，与超微电脑联手探索核能AI数据中心>>
05-07 19:09
12 Industrials Stocks Moving In Wednesday's Intraday Session
Gainers BlueLinx Hldgs (NYSE:BXC) stock moved upwards by 28.8% to $59.5 during...
05-07 01:05
Bluelinx Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.
Bluelinx Holdings shares are trading higher after the company reported better-t...
05-06 23:48
Transcript: BlueLinx Hldgs Q1 2026 Earnings Conference Call
BlueLinx Hldgs (NYSE:BXC) reported first-quarter financial results on Wednesday...
05-06 22:51
BlueLinx Hldgs Q1 Adj. EPS $0.21 Beats $(0.72) Estimate, Sales $731.149M Beat $714.843M Estimate
BlueLinx Hldgs (NYSE:BXC) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $(0.72) by 129.17 percent. This is a 22.22 percent decrease over earnings of $0.27 per share from the
05-06 04:14
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Shares of homebuilding and housing-related companies are trading lower after U.S. mortgage rates grew for the fifth straight week, with the 30-year near a 7-month high.
Shares of homebuilding and housing-related companies are trading lower after U....
04-03 01:06
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $75
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $83 to $75.
02-28 01:32
